Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05588245 · ClinicalTrials.gov registry record · NA
Trial of Community-based Patient Navigation
A NA study of Pregnancy Related, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 540
- Enrollment target
- 1
- Study location
NCT05588245: Recruiting NA study of Pregnancy Related, sponsored by Emory University.
NCT05588245 is a NA study of Pregnancy Related that is actively recruiting participants, run by Emory University. The registered enrollment target is 540 participants, below the 1,958-participant average among 99 other Pregnancy Related trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05588245, a NA study of Pregnancy Related, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness of a community-based patient navigator intervention from mid-pregnancy through 12 month postpartum for a high-risk population of medically underserved women. The RCT will enroll 540 pregnant women before 20 weeks of pregnancy and randomly allocate them into two different study arms from the time of prenatal enrollment through 12 months postpartum. If found to be effective, the community-based patient navigator intervention can be implemented as a standard of care at Grady and other provider practices serving high-risk women to improve maternal health outcomes and reduce racial disparities.
Primary Outcome
This is a count measure that reflects the total number of SMM and/or death events during the delivery admission through 12-months of delivery according to the presence/absence of the 21 SMM indicator diagnosis codes (as published by the Centers for Disease Control and Prevention) and/or a death event documented in the EPIC electronic medical record.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL Community-based prenatal/perinatal/postpartum patient navigator
Study Locations (1)
Georgia
- Grady Memorial Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2024-01-25 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT05588245 shows while recruiting
NCT05588245 is an interventional study that assigns participants to a tested intervention. The registered 540 participants enrollment target is mid-sized for trials with a published cap, below the 1,958-participant average among 99 other Pregnancy Related trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT05588245 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05588245 about?
NCT05588245 is a clinical study titled "Trial of Community-based Patient Navigation". This study will test the effectiveness of a community-based patient navigator intervention from mid-pregnancy through 12 month postpartum for a high-risk population of medically underserved women. The RCT will enroll 540 pregnant women before 20 weeks of pregnancy and randomly allocate them into two...
What is the current status of trial NCT05588245?
This trial is currently recruiting. It is a NA study. The enrollment target is 540 participants. The study started on 2024-01-25. Estimated completion is 2027-06.
What conditions does trial NCT05588245 study?
This clinical trial studies the following conditions: Pregnancy Related.
What interventions are being tested in trial NCT05588245?
The interventions under investigation include: Standard of Care (BEHAVIORAL), Community-based prenatal/perinatal/postpartum patient navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT05588245?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05588245 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05588245's enrollment target sits among peer trials
540 27th of 99 higher than 73 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05429892 · 540 participants · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI